JAGX vs. GOVX, TRIB, RLYB, ERNA, COCP, ABP, EDSA, MBRX, UBX, and MEIP
Should you be buying Jaguar Health stock or one of its competitors? The main competitors of Jaguar Health include GeoVax Labs (GOVX), Trinity Biotech (TRIB), Rallybio (RLYB), Eterna Therapeutics (ERNA), Cocrystal Pharma (COCP), Abpro (ABP), Edesa Biotech (EDSA), Moleculin Biotech (MBRX), Unity Biotechnology (UBX), and MEI Pharma (MEIP). These companies are all part of the "pharmaceutical products" industry.
Jaguar Health vs.
GeoVax Labs (NASDAQ:GOVX) and Jaguar Health (NASDAQ:JAGX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, community ranking, earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and media sentiment.
GeoVax Labs has a net margin of 0.00% compared to Jaguar Health's net margin of -360.13%. Jaguar Health's return on equity of -326.62% beat GeoVax Labs' return on equity.
In the previous week, Jaguar Health had 3 more articles in the media than GeoVax Labs. MarketBeat recorded 4 mentions for Jaguar Health and 1 mentions for GeoVax Labs. GeoVax Labs' average media sentiment score of 1.22 beat Jaguar Health's score of 0.24 indicating that GeoVax Labs is being referred to more favorably in the media.
GeoVax Labs has a beta of 3.47, meaning that its stock price is 247% more volatile than the S&P 500. Comparatively, Jaguar Health has a beta of 0.94, meaning that its stock price is 6% less volatile than the S&P 500.
GeoVax Labs presently has a consensus target price of $11.10, suggesting a potential upside of 999.01%. Jaguar Health has a consensus target price of $60.00, suggesting a potential upside of 1,236.30%. Given Jaguar Health's higher possible upside, analysts plainly believe Jaguar Health is more favorable than GeoVax Labs.
GeoVax Labs has higher earnings, but lower revenue than Jaguar Health.
6.1% of GeoVax Labs shares are held by institutional investors. Comparatively, 12.0% of Jaguar Health shares are held by institutional investors. 1.2% of GeoVax Labs shares are held by insiders. Comparatively, 0.4% of Jaguar Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Jaguar Health received 1806 more outperform votes than GeoVax Labs when rated by MarketBeat users. However, 96.77% of users gave GeoVax Labs an outperform vote while only 88.61% of users gave Jaguar Health an outperform vote.
Summary
GeoVax Labs beats Jaguar Health on 10 of the 17 factors compared between the two stocks.
Get Jaguar Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Jaguar Health Competitors List
Related Companies and Tools
This page (NASDAQ:JAGX) was last updated on 5/23/2025 by MarketBeat.com Staff
Buy JAGX Stock Free JAGX Stock Alerts